Application Nr Approved Date Route Status External Links
NDA010104 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Phytonadione Tablets Are Indicated In The Following Coagulation Disorders Which Are Due To Faulty Formation Of Factors Ii,vii, Ix And X When Caused By Vitamin K Deficiency Or Interference With Vitamin K Activity. Phytonadione Tablets Are Indicated In: • Anticoagulant-Induced Prothrombin Deficiency Caused By Coumarin Or Indanedione Derivatives; • Hypoprothrombinemia Secondary To Antibacterial Therapy; • Hypoprothrombinemia Secondary To Administration Of Salicylates; • Hypoprothrombinemia Secondary To Obstructive Jaundice Or Biliary Fistulas But Only If Bile Salts Are Administered Concurrently, Since Otherwise The Oral Vitamin K Will Not Be Absorbed.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Phytonadione PHYTONADIONE ZINC3831332

Comments